Suppr超能文献

口服塞来昔布与口服双氯芬酸用于自然阴道分娩后会阴修补术后镇痛的随机试验。

Oral celecoxib versus oral diclofenac for post-perineal repair analgesia after spontaneous vaginal birth: a randomised trial.

作者信息

Lim Soo Soo, Tan Peng Chiong, Sockalingam Jayanthi Karen, Omar Siti Zawiah

机构信息

Department of Obstetrics and Gynaecology, Maternity Hospital Penang, Penang, Malaysia.

出版信息

Aust N Z J Obstet Gynaecol. 2008 Feb;48(1):71-7. doi: 10.1111/j.1479-828X.2007.00808.x.

Abstract

OBJECTIVE

To compare oral celecoxib with oral diclofenac as pain reliever after perineal repair following normal vaginal birth.

METHODS

One hundred and sixty-four and 165 women, respectively, were randomised to 200 mg celecoxib or to 100 mg diclofenac orally 12 hourly for 24 h after perineal repair. A ten-point visual analog scale (VAS) for pain recorded at one, two, four, eight, 12 and 24 hours at rest and when mobilising was the primary outcome.

RESULTS

Repeated measures analysis of variance showed a larger reduction of VAS pain score at rest with celecoxib compared to diclofenac (P = 0.044). Mean VAS pain score at rest was 2.2 versus 2.7, 2.1 versus 2.5, 1.8 versus 2.2, 1.6 versus 1.6, 1.3 versus 1.4 at one, two, four, eight, 12 and 24 hours, respectively, for celecoxib versus diclofenac. The difference in pain score when mobilising was not significant (P = 0.75). Univariate analyses with the Student's t-test indicated significantly lower pain score at rest only at one, two and four hours with celecoxib. Randomisation to celecoxib was associated with less upper gastrointestinal symptoms reported: 38 of 163 (23.3%) versus 57 of 165 (34.5%) (relative risk 0.67 95% CI 0.48-0.96: P = 0.029) but additional analgesia for breakthrough pain was not significantly different eight of 161 (5.0%) versus 18 of 165 (10.9%) (relative risk 0.46 95% CI 0.20-1.01: P = 0.065).

CONCLUSION

Celecoxib was associated with a slightly lower VAS pain score at rest and less upper gastrointestinal symptoms were reported when compared to diclofenac.

摘要

目的

比较口服塞来昔布与口服双氯芬酸在正常阴道分娩会阴修复术后作为止痛剂的效果。

方法

164名和165名女性分别被随机分配,在会阴修复术后24小时内每12小时口服200毫克塞来昔布或100毫克双氯芬酸。主要观察指标是在静息和活动状态下,于1、2、4、8、12和24小时记录的10分视觉模拟疼痛量表(VAS)评分。

结果

重复测量方差分析显示,与双氯芬酸相比,塞来昔布使静息状态下的VAS疼痛评分降低幅度更大(P = 0.044)。塞来昔布与双氯芬酸相比,在1、2、4、8、12和24小时静息状态下的平均VAS疼痛评分分别为2.2对2.7、2.1对2.5、1.8对2.2、1.6对1.6、1.3对1.4。活动时的疼痛评分差异不显著(P = 0.75)。采用学生t检验的单因素分析表明,仅在1、2和4小时静息状态下,塞来昔布的疼痛评分显著更低。随机分配至塞来昔布组报告的上消化道症状较少:163例中有38例(23.3%),而165例中有57例(34.5%)(相对风险0.67,95%可信区间0.48 - 0.96:P = 0.029),但突破性疼痛的额外镇痛情况无显著差异,161例中有8例(5.0%),而165例中有18例(10.9%)(相对风险0.46,95%可信区间0.20 - 1.01:P = 0.065)。

结论

与双氯芬酸相比,塞来昔布与静息状态下稍低的VAS疼痛评分相关,且报告的上消化道症状较少。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验